收费全文 | 4740篇 |
免费 | 325篇 |
国内免费 | 35篇 |
耳鼻咽喉 | 84篇 |
儿科学 | 114篇 |
妇产科学 | 45篇 |
基础医学 | 572篇 |
口腔科学 | 121篇 |
临床医学 | 387篇 |
内科学 | 1340篇 |
皮肤病学 | 31篇 |
神经病学 | 324篇 |
特种医学 | 199篇 |
外科学 | 809篇 |
综合类 | 23篇 |
一般理论 | 1篇 |
预防医学 | 123篇 |
眼科学 | 154篇 |
药学 | 249篇 |
中国医学 | 3篇 |
肿瘤学 | 521篇 |
2024年 | 11篇 |
2023年 | 99篇 |
2022年 | 177篇 |
2021年 | 314篇 |
2020年 | 152篇 |
2019年 | 167篇 |
2018年 | 191篇 |
2017年 | 144篇 |
2016年 | 178篇 |
2015年 | 156篇 |
2014年 | 174篇 |
2013年 | 239篇 |
2012年 | 372篇 |
2011年 | 421篇 |
2010年 | 201篇 |
2009年 | 138篇 |
2008年 | 237篇 |
2007年 | 243篇 |
2006年 | 203篇 |
2005年 | 198篇 |
2004年 | 169篇 |
2003年 | 170篇 |
2002年 | 160篇 |
2001年 | 24篇 |
2000年 | 31篇 |
1999年 | 36篇 |
1998年 | 32篇 |
1997年 | 26篇 |
1996年 | 26篇 |
1995年 | 29篇 |
1994年 | 29篇 |
1993年 | 20篇 |
1992年 | 37篇 |
1991年 | 24篇 |
1990年 | 26篇 |
1989年 | 29篇 |
1988年 | 18篇 |
1987年 | 18篇 |
1986年 | 21篇 |
1985年 | 14篇 |
1984年 | 16篇 |
1983年 | 16篇 |
1982年 | 11篇 |
1981年 | 10篇 |
1980年 | 10篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1976年 | 11篇 |
1975年 | 12篇 |
1974年 | 16篇 |
Familial pancreatic cancer (FPC) is defined as a family in which at least two first-degree relatives have pancreatic cancer (PC). The prognostic significance of PC in an FPC family after surgery is not fully understood.
MethodsThis was a retrospective study of 427 patients who underwent pancreatectomy for pancreatic ductal adenocarcinoma between January 2008 and December 2016. PC patients who also had at least one first-degree relative with PC were defined as FPC patients. The associations between recurrence and clinicopathological characteristics were analyzed for both FPC and non-FPC patients.
ResultsFPC patients accounted for 31 of the 427 (7.3%) patients. Recurrence occurred in 72.1% of the total cohort and in 87.1% of the 31 FPC patients. Multivariate analysis showed that being an FPC patient was an independent predictor for relapse-free survival (RFS) (hazard ratio [HR] 1.52, P = 0.038). Although univariate analysis revealed that being an FPC patient was significantly associated with poorer overall survival (OS) (P < 0.001), multivariate analysis showed that being an FPC patient was not an independent predictor for OS (P = 0.164). Dichotomization of the 427 patients into those who received (n = 317: 17 FPC and 300 non-FPC patients) and did not receive (n = 110: 14 FPC and 96 non-FPC patients) adjuvant chemotherapy revealed that being an FPC patient was an independent predictor for RFS (HR 2.50, P < 0.001) and OS (HR 2.30, P = 0.003) only for patients who received adjuvant chemotherapy.
ConclusionsThis study has shown that being an FPC patient is a significant prognostic indicator for PC patients who undergo resection and receive adjuvant chemotherapy.
相似文献